Iceland· IS-EU/1/22/1683/001
Vabysmo
A faricimab product containing faricimabum inn, registered in Iceland by Roche Registration GmbH*. The same ATC class is registered in 14 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Faricimab is registered in 14 of 19 countries.
Countries holding a registration under ATC S01LA09 (faricimab), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 9 of them publish a price we can compare per daily dose
Faricimab · ATC S01LA09
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Faricimabum INN
- Manufacturer
- Roche Registration GmbH*
- Country
- Iceland (IS)
- ATC code
- S01LA09
- ATC class
- Faricimab
- Defined daily dose
- 0.0357 DE, IVT
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 2
2 priced- ean0603110,175 ml x1 áfsprISK 148791
- ean1880480,24 ml x1 hglISK 140410
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Faricimab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainVABYSMO 120 MG/ML SOLUCION INYECTABLERoche Registration Gmbh
- SwitzerlandVabysmo 6 mg/0,05 ml, InjektionslösungRoche Pharma (Schweiz) AG
- CzechiaVABYSMORoche Registration GmbH, Grenzach-Wyhlen
- SwedenVABYSMO 120 mg/ml Injektionsvätska, lösningRoche Registration GmbH
- IrelandVabysmo 120 mg/mL solution for injectionRoche Registration GmbH
- NorwayVabysmoRoche Registration GmbH
- BelgiumVabysmo 120 mg/mlRoche Registration
- NetherlandsVabysmo 120 mg/ml, oplossing voor injectieRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Vabysmo
- Norway · Vabysmo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/345af081-a892-4153-b49e-ef4d3189e488 GET /v1/drugs/345af081-a892-4153-b49e-ef4d3189e488?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "S01LA09",
"marketed": true,
"strength": "120 mg/ml",
"ma_number": "EU/1/22/1683/001",
"substance": "Faricimabum INN",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "44819"
}See everything about faricimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.